Asset One Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.45M Buy
74,866
+1,954
+3% +$114K 0.49% 52
2025
Q4
$4.08M Buy
+72,912
New +$3.51M 0.56% 47

Other funds holding BMY

Asset One Wealth Management's BMY Position: Q1 2026 in Review

Asset One Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 2.7% in Q1 2026, buying an estimated $114K and bringing the position to 74,866 shares worth $4.45M. The position accounts for 0.49% of the portfolio, ranked #52.

Asset One Wealth Management first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Asset One Wealth Management held 74,866 shares of Bristol-Myers Squibb worth $4.45M as of Q1 2026.
  • Asset One Wealth Management bought 1,954 Bristol-Myers Squibb shares in Q1 2026, an estimated $114K.
  • Bristol-Myers Squibb made up 0.49% of Asset One Wealth Management's portfolio in Q1 2026, its #52 holding.
  • Asset One Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Asset One Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.